Stay updated on MK-2640 Safety and Efficacy in Diabetes Clinical Trial

Sign up to get notified when there's something new on the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the safety, pharmacokinetics, and pharmacodynamics evaluation of MK-2640 in healthy participants and participants with Type 1 Diabetes Mellitus.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:56.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying health conditions and prior treatments required for inclusion. Previously, this section only indicated that no information was provided.
    Difference
    31%
    Check dated 2024-05-22T21:03:51.000Z thumbnail image
  8. Check
    42 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:28:07.000Z thumbnail image

Stay in the know with updates to MK-2640 Safety and Efficacy in Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page.